SARAH M SCHWERTNER

Allopathic & Osteopathic Physicians|General Practice METAIRIE, LA NPI 1992062897

General Payments — all program years on this page

$3,992.33

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 218
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $366.98 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $366.9821

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,743.1895
2019 $891.9844
2020 $76.315
2021 $102.414
2022 $292.2917
2023 $519.1832
2024 $366.9821

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086118764 Bayer Healthcare Pharmaceuticals Inc. $18.84 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086152781 Bayer Healthcare Pharmaceuticals Inc. $14.08 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097768176 Novo Nordisk Inc $17.33 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103829088 ABBVIE INC. $15.69 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105414641 AstraZeneca Pharmaceuticals LP $13.50 06/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105514047 AstraZeneca Pharmaceuticals LP $23.77 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114681296 Exact Sciences Corporation $21.78 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115912350 GlaxoSmithKline, LLC. $13.83 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116379890 GlaxoSmithKline, LLC. $15.96 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116556661 GlaxoSmithKline, LLC. $15.41 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118263399 Boehringer Ingelheim Pharmaceuticals, Inc. $18.82 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118263401 Boehringer Ingelheim Pharmaceuticals, Inc. $22.21 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131587119 PFIZER INC. $19.55 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131597015 PFIZER INC. $17.64 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131614488 PFIZER INC. $17.73 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131643955 PFIZER INC. $16.92 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131657643 PFIZER INC. $17.78 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135392349 Lilly USA, LLC $16.32 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135395303 Lilly USA, LLC $16.99 01/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135408005 Lilly USA, LLC $17.54 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153334427 Dexcom, Inc. $15.29 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.